![](/img/cover-not-exists.png)
Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivo
Jacobino, Shamir R., Nederend, Maaike, Reijneveld, J. Frederiek, Augustijn, Daan, Jansen, J. H. Marco, Meeldijk, Jan, Reiding, Karli R., Wuhrer, Manfred, Coenjaerts, Frank E. J., Hack, C. Erik, Bont,Language:
english
Journal:
mAbs
DOI:
10.1080/19420862.2018.1433974
Date:
March, 2018
File:
PDF, 1.52 MB
english, 2018